Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6706 AL 6720

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.

Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?

Matos MJ.

Future Med Chem. 2021 Aug;13(15):1301-1309. doi: 10.4155/fmc-2021-0119. Epub 2021 Jun 17.

Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer's disease

Chan D, Suk HJ, Jackson B, Milman NP, Stark D, Beach SD, Tsai LH.

J Intern Med. 2021 Nov;290(5):993-1009. doi: 10.1111/joim.13329. Epub 2021 Jun 22.

Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines

Milane L, Dolare S, Jahan T, Amiji M.

Nanomedicine. 2021 Oct;37:102422. doi: 10.1016/j.nano.2021.102422. Epub 2021 Jun 25.

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, Yuan Y, Li L.

Neurosci Bull. 2021 Oct;37(10):1510-1522. doi: 10.1007/s12264-021-00730-8. Epub 2021 Jul 3.

Therapeutic potential of catalpol and geniposide in Alzheimer's and Parkinson's diseases: A snapshot of their underlying mechanisms

Zhang X, Liu K, Shi M, Xie L, Deng M, Chen H, Li X.

Brain Res Bull. 2021 Sep;174:281-295. doi: 10.1016/j.brainresbull.2021.06.020. Epub 2021 Jul 1.

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases

Jagaran K, Singh M.

Int J Mol Sci. 2021 Aug 23;22(16):9082. doi: 10.3390/ijms22169082.

Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease

Pacheco-Herrero M, Soto-Rojas LO, Reyes-Sabater H, Garcés-Ramirez L, de la Cruz López F, Villanueva-Fierro I, Luna-Muñoz J.

J Alzheimers Dis. 2021;84(3):917-935. doi: 10.3233/JAD-200863.

Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics

Soliman HM, Ghonaim GA, Gharib SM, Chopra H, Farag AK, Hassanin MH, Nagah A, Emad-Eldin M, Hashem NE, Yahya G, Emam SE, Hassan AEA, Attia MS.

Int J Mol Sci. 2021 Oct 6;22(19):10794. doi: 10.3390/ijms221910794.

The Role and Mechanisms of Action of Catechins in Neurodegenerative Diseases

Özduran G, Becer E, Vatansever HS.

J Am Nutr Assoc. 2023 Jan;42(1):67-74. doi: 10.1080/07315724.2021.1981487. Epub 2021 Nov 24.

Advancements and future directions in research of the roles of insulin in amyloid diseases

Miller Y.

Biophys Chem. 2022 Feb;281:106720. doi: 10.1016/j.bpc.2021.106720. Epub 2021 Nov 17.

Advances in Parkinson's Disease Drugs

Di Stefano A, Marinelli L.

Biomolecules. 2021 Nov 5;11(11):1640. doi: 10.3390/biom11111640.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias